Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
用于癌症治疗的新型治疗性抗体对 Fcγ 受体独立的 CD40 典型信号传导进行控制激活
期刊:Antibodies
影响因子:
doi:10.3390/antib13020031
Karsten Beckmann, Carmen Reitinger, Xianglei Yan, Anna Carle, Eva Blümle, Nicole Jurkschat, Claudia Paulmann, Sandra Prassl, Linda V Kazandjian, Karin Loré, Falk Nimmerjahn, Stephan Fischer